A mutation in MMR genes or an alteration in DNA methylation markers can lead to a cumulative increase in genetic or epigenetic errors, which can contribute to tumor occurrence (Butler et al., 2020; Georgakopoulos-Soares et al., 2020). Here, MRC1 is linked to neoplasm.